Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies
AbstractBackground The aim of this study was to assess the diagnostic performance of an autoantibody battery in patients receiving immune checkpoint inhibitors who experienced immune-related adverse events (irAEs).Methods We retrospectively analyzed several variables potentially related to irAEs, na...
Main Authors: | Iñigo Les, Mireia Martínez, Alicia Narro, Inés Pérez, Cristina Sánchez, Laura Puntí, Pilar Anaut, Saioa Eguiluz, Alberto Herrera, Severina Domínguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2021.1931956 |
Similar Items
-
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study
by: Iñigo Les, et al.
Published: (2022-06-01) -
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
by: Zhou S, et al.
Published: (2019-01-01) -
Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
by: Bianca Gautron Moura, et al.
Published: (2022-12-01) -
Clinical utility of nivolumab in the treatment of advanced melanoma
by: Asmar R, et al.
Published: (2016-02-01) -
Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature
by: Cristina-Florina Pîrlog, et al.
Published: (2022-12-01)